EUVIMEDEUVIMED entdecken
Crossref

RETRACTED: Gefitinib-Loaded Starch/Chitosan Polymeric Nanoparticles for Enhanced Colorectal Cancer Therapy: Network Pharmacology, Molecular Docking, Physicochemical Characterization, and Evaluation in HCT-116 Cells and DMH-Induced Wistar Rats

Megha Jha, Sankha Bhattacharya, Girdhari Lal Gupta, Preeti Chidambar Sangave, Vishal Beldar, Satyam Sharma, Suprit D. Saoji, Mahaveer Singh

ACS Nano Medicine · 09.09.2026 · 1 (8) · 2028-2070

DOI: 10.1021/acsnanomed.6c00094 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano Medicine, online erschienen am 18.06.2026. Verfasst von Megha Jha und 7 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 189 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Gefitinib-loaded potato starch-chitosan nanoparticles (GEF-PS-CS-NPs) designed for the treatment of colorectal cancer had a size range of 190 ± 18.7 to 210 ± 20.45 nm, a zeta potential range of +2.26 ± 0.56 to +10.5 ± 2.67 mV, and an entrapment efficiency range of 66.5 ± 6.45 to 76.6 ± 8.45%. The application of 4–8% w/v potato starch increased the size (p < 0.7154) and zeta potential of the nanoparticles owing to the swelling effect and electrostatic interaction. In silico network pharmacology study (STRING/Cytoscape) identified EGFR/SRC/MAPK hubs in CRC PPI networks, which were further corroborated by molecular docking and experimental validation in HCT116 cells and DMH-induced rats. Schrödinger docking research indicated high-affinity gefitinib binding to EGFR (Glide scores of −8.2 to −9.1 kcal/mol), corroborating the hypothesized EGFR-mediated mechanism. In vitro, GEF-PS-CS-NPs exhibited higher cytotoxicity against HCT116 CRC cells. GEF-PS-CS-NPs decreased BCL2 levels and triggered apoptotic DNA fragmentation in HCT116 CRC cells, confirming downstream reduction of survival signaling predicted by network pharmacology. The induction of 1,2-dimethylhydrazine (DMH) resulted in tumor formation, aberrant crypt foci, and biochemical changes in colorectal cancer-induced Wistar rats. GEF-PS-CS-NPs had 20-fold greater AUC (3690 ng·h/mL), increased t1/2 (29 h vs 14 h), increased Cmax (6.9 ng/mL), and increased Vd (2361 mL) compared with free GEF. GEF-PS-CS-NPs showed hemolysis below 5% and minimal platelet aggregation. Histopathology showed reduced colon damage and significantly improved inflammatory/oxidative markers, validating the pharmacological relevance of the expected EGFR/PI3K-AKT-associated anticancer effect. GEF-PS-CS-NPs confirmed as a promising nanocarrier for the treatment of colorectal cancer.

Zitieren

APA

Jha, M., Bhattacharya, S., Gupta, G. L., Sangave, P. C., Beldar, V., Sharma, S., Saoji, S. D., & Singh, M. (2026). RETRACTED: Gefitinib-Loaded Starch/Chitosan Polymeric Nanoparticles for Enhanced Colorectal Cancer Therapy: Network Pharmacology, Molecular Docking, Physicochemical Characterization, and Evaluation in HCT-116 Cells and DMH-Induced Wistar Rats. ACS Nano Medicine, 1(8), 2028-2070. https://doi.org/10.1021/acsnanomed.6c00094

Vancouver

Jha M, Bhattacharya S, Gupta GL, Sangave PC, Beldar V, Sharma S, et al. RETRACTED: Gefitinib-Loaded Starch/Chitosan Polymeric Nanoparticles for Enhanced Colorectal Cancer Therapy: Network Pharmacology, Molecular Docking, Physicochemical Characterization, and Evaluation in HCT-116 Cells and DMH-Induced Wistar Rats. ACS Nano Medicine. 2026;1(8):2028-2070. doi:10.1021/acsnanomed.6c00094

BibTeX
@article{Jha2026,
  author = {Jha, Megha and Bhattacharya, Sankha and Gupta, Girdhari Lal and Sangave, Preeti Chidambar and Beldar, Vishal and Sharma, Satyam and Saoji, Suprit D. and Singh, Mahaveer},
  title = {RETRACTED: Gefitinib-Loaded Starch/Chitosan Polymeric Nanoparticles for Enhanced Colorectal Cancer Therapy: Network Pharmacology, Molecular Docking, Physicochemical Characterization, and Evaluation in HCT-116 Cells and DMH-Induced Wistar Rats},
  journal = {ACS Nano Medicine},
  year = {2026},
  volume = {1},
  number = {8},
  pages = {2028--2070},
  doi = {10.1021/acsnanomed.6c00094}
}
Kostenlos starten →